Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system.
about
Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosisMycobacterium avium strains resistant to clarithromycin and azithromycinRapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulareFish tank granuloma caused by Mycobacterium marinumMultisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex.Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.Mycobacterial skin and soft tissue infection.Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients.Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens.In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycinAntimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteriaInfection and panniculitis.Short course monotherapy with clarithromycin for localized Mycobacterium marinum skin infection.Disseminated Mycobacterium scrofulaceum Infection in an Immunocompetent HostGenetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus.Antimicrobial agent resistance in mycobacteria: molecular genetic insights.Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare.Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes.Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis.Bacteriological and virulence study of a Mycobacterium chimaera isolate from a patient in China.Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease.Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study.Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group.Successful treatment of localized cutaneous infection caused by Mycobacterium scrofulaceum with clarithromycin.Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.Two dd-Carboxypeptidases from Mycobacterium smegmatis Affect Cell Surface Properties through Regulation of Peptidoglycan Cross-Linking and GlycopeptidolipidsTherapy for Infection: Beyond 2018
P2860
Q28367457-F0338243-2D6F-4EEC-8DCD-5C439AFB7F91Q28369301-F0ED3909-3DD2-4D84-9331-A8BF5E57070DQ28379494-8B18747E-AF76-476C-A50D-FE3723E056C5Q34387801-26A85A15-CA8D-4567-A77B-19442A5B2944Q34750943-3A17ACD6-2E2E-427D-B2AE-3965F2779765Q35111440-D69BD38C-B56E-426F-B79A-1A85F85349F8Q35359858-1E7FB0D2-500F-4EAE-A0CC-222D69FB35FCQ35779935-7D708C20-5E42-4BA7-B518-F50402669605Q35797447-16FB3134-E3F4-4477-9074-E65283DA5C78Q35904249-4D88B684-2795-43CA-8094-569F3F25DD1DQ36156072-E7B52B33-A254-4CE1-B962-C634CE14959DQ36201896-879025B1-792F-4943-87A7-A0C92CC74DBFQ37776289-965D94BF-49D9-4A44-B299-8530505F1730Q38003606-A213032D-5D3D-4FC9-8A62-FBE159230E82Q39152747-155CE5E6-F010-463C-AEE2-058E8CB09FC0Q39782444-06DD6606-DE5F-42CD-BA7A-29BE282AC40EQ39820619-1B25E480-2F33-472F-BB34-0AA1AE33692DQ40285103-EB77F5E4-970C-4946-8D6C-394E4D128CACQ40285786-8D05407E-033A-41D7-A732-2EF0C05BF5D8Q40425898-DC2213BE-EC04-4080-AC9C-7D9D9C6C0AF7Q40588136-2FE67ECA-8825-45B0-BFF4-D8E5823F417DQ41435935-357FEB96-250A-4ECD-B50A-9ECE4069BA27Q43599614-8914279F-CDD1-4FDA-AC66-9957BA9D6477Q44616837-8515D80E-3A66-411D-AAC8-D4D995CDCADFQ44915723-E604B5FE-8373-4F18-88D3-C7BCDD128E68Q46725941-5D275346-DC3D-4306-B516-AC3B2420DCF9Q54080322-C6B42D88-8870-4A63-AD0B-3D3980C37954Q57179156-C6AE20A1-C6CB-47E2-9CA0-BAAA79A347BAQ57492415-89EFE034-3BC2-45B7-80B7-BBA1552BA3CE
P2860
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Activities of clarithromycin a ...... roth microdilution MIC system.
@en
Activities of clarithromycin a ...... roth microdilution MIC system.
@nl
type
label
Activities of clarithromycin a ...... roth microdilution MIC system.
@en
Activities of clarithromycin a ...... roth microdilution MIC system.
@nl
prefLabel
Activities of clarithromycin a ...... roth microdilution MIC system.
@en
Activities of clarithromycin a ...... roth microdilution MIC system.
@nl
P2093
P2860
P356
P1476
Activities of clarithromycin a ...... roth microdilution MIC system.
@en
P2093
P2860
P304
P356
10.1128/AAC.36.9.1987
P407
P577
1992-09-01T00:00:00Z